Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
UBS
Fish and Richardson
Healthtrust
Colorcon
Harvard Business School
QuintilesIMS
Accenture
Johnson and Johnson
Dow

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070929

« Back to Dashboard

NDA 070929 describes TAMOXIFEN CITRATE, which is a drug marketed by Actavis Labs Fl Inc, Aegis Pharms, Apotex, Ivax Sub Teva Pharms, Mayne Pharma, Mylan, Pharmachemie, Roxane, Teva, and Zydus Pharms Usa Inc, and is included in eleven NDAs. It is available from thirteen suppliers. Additional details are available on the TAMOXIFEN CITRATE profile page.

The generic ingredient in TAMOXIFEN CITRATE is tamoxifen citrate. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.
Summary for 070929
Tradename:TAMOXIFEN CITRATE
Applicant:Actavis Labs Fl Inc
Ingredient:tamoxifen citrate
Patents:0
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 070929
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 070929 ANDA Actavis Pharma, Inc. 0591-2472 N 0591-2472-60
TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 070929 ANDA Actavis Pharma, Inc. 0591-2472 N 0591-2472-18

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Feb 20, 2003TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Feb 20, 2003TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
Baxter
Healthtrust
Federal Trade Commission
Accenture
Harvard Business School
Fuji
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot